Placebo-controlled double blind study of the efficacy of Curcumin in patients with NAFLD/NASH

Placebo-controlled double blind study of the efficacy of Curcumin in patients with NAFLD/NASH - Placebo-controlled double blind study of the efficacy of Curcumin in patients with NAFLD/NASH

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000007015

Enrollment

Registered

2012-01-04

Start date

2012-01-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

NAFLD/NASH

Interventions

Curcumin/Placebo Placebo/Curcumin

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1.patients diagnosed as NAFLD/NASH 2.PS0-2 3.patients being consent to this study.

Exclusion criteria

Exclusion criteria: 1.patients having other severe complications. 2.patients incapable of oral intake.

Design outcomes

Primary

Measure	Time frame
The efficacy of Curcumin in patients with NAFLD/NASH.	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026